Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)

Completed

Conditions studied: Epilepsy, Pregnancy

In brief

Epilepsy is one of the most common neurological disorders affecting women of childbearing age. Poor pregnancy outcomes are increased in these women and their children. The proposed studies will increase our knowledge on multiple levels to improve care and reduce adverse outcomes in these mothers and children. An overall goal of this study is to establish the relationship between antiepileptic drug exposure and outcomes in the mother and child as well as describe and explain the variability in antiepileptic drug exposure and response.

Key facts

Study ID
NCT01730170
Run by
Stanford University
People needed
565
Starts
2013-01-01
Expected to finish
2022-12-12
Last updated by the study team
2023-07-13

Who can join

Age: 14 and older, up to 45. Sex: female. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.